The present invention provides methods for treating cannabinoid sensitive disorders with a lose dose oral cannabinoid which results in delivery of a therapeutic level during an extended clinically relevant therapeutic window. These methods provide therapeutic dosing while maintaining safe side effect sparing levels of a cannabinoid. The present invention also provides methods of determining optimal dosing in treated patients.